Description
A premium standardized extract of Hawthorn leaves, flowers, and berries (Crataegus pinnatifida or Crataegus monogyna), containing 80 percent total flavonoids (including vitexin, hyperoside, rutin, and quercetin glycosides). The principal cardiovascular botanical of European herbal medicine, used widely in Germany, France, and other European markets.
Yellow-brown to brown free-flowing powder. Highly water-soluble.
We supply food-grade Hawthorn Flavonoids 80% from manufacturers in China holding ISO, Halal, Kosher and other certifications relevant to the product and production.
Companion market grades include 1.8 percent Vitexin (the historical European pharmacopoeia specification), 5 percent Flavonoids (cost-effective baseline), 10 percent Flavonoids (standard supplement grade), 25 percent OPC (oligomeric proanthocyanidin-standardized grade), and the 80 percent total flavonoids grade documented here.
Bulk and reduced-MOQ shipments. Batch-level COA covering total flavonoids (UV), vitexin content (HPLC), hyperoside content, residual solvents, heavy metals, pesticides, and microbiology.
Introduction
Hawthorn has been used as a cardiovascular herb in European traditional medicine since at least the 16th century. The plant remains among the most-prescribed herbal medicines in modern German medical practice, with multiple pharmacopoeia monographs and approved phytopharmaceutical preparations for mild cardiac insufficiency.
Industrial production proceeds by ethanol or hydroalcoholic extraction of dried Hawthorn leaves, flowers, and berries, followed by purification and concentration to defined flavonoid content.
Recognized as a permitted food ingredient by the U.S. FDA, the European Food Safety Authority, and equivalent regulators worldwide. The European Medicines Agency has issued monographs for Hawthorn as a traditional herbal medicine for mild cardiac symptoms.
Clinical evidence for Hawthorn in mild-to-moderate cardiac insufficiency is among the strongest for any botanical cardiovascular ingredient, with multiple controlled trials supporting effects on exercise tolerance and symptomatic endpoints in defined patient populations.
Strategic positioning targets cardiovascular and heart-health dietary supplements globally, with the high-flavonoid specification supporting premium positioning over conventional Hawthorn extracts.
Where it is used
- Cardiovascular-support dietary supplements: heart-health and circulation-positioned formulations
- Blood-pressure-support supplement formulations
- Traditional European herbal medicine: cardiac and circulatory applications
- Premium pharmaceutical-grade herbal medicines (where Hawthorn is approved as a treatment for mild cardiac insufficiency in some European markets)
- Combination cardiovascular supplements with CoQ10, omega-3, and other cardiac actives
- Functional beverages: cardiovascular wellness shots
- Premium pet supplements positioned for senior pet cardiac health
Technical data
| Item | Specification |
|---|---|
| Appearance | Yellow-brown to brown free-flowing powder |
| Total flavonoids (UV) | ≥ 80% |
| Vitexin (HPLC) | ≥ 1.8% |
| Hyperoside (HPLC) | ≥ 0.5% |
| Loss on drying | ≤ 5.0% |
| Residue on ignition | ≤ 5.0% |
| Heavy metals (as Pb) | ≤ 2 mg/kg |
| Source | Crataegus pinnatifida or C. monogyna leaves, flowers, and fruit |
Ready to discuss business?
Send us your spec and requirement. We will respond with availability and pricing within 24 hours.